Why Your Body Needs Extra Nutrients While on Weight-Loss Medications
New weight-loss drugs are changing how doctors treat obesity and type 2 diabetes. Medications like semaglutide and tirzepatide help…
-
-
Shame and Stigma Affect the GLP-1 Treatment Journey
Weight stigma has a measurable impact on clinical outcomes during pharmacological treatment for obesity. Glucagon-like peptide-1 receptor agonists, like…
-
GLP-1 Therapy Linked to Sensory Disturbances in Type 2 Diabetes
Long-term use of glucagon-like peptide 1 receptor agonists is linked to a higher risk of disturbances in smell and…
-
Researchers Find Which GLP-1 Treatment Delivers the Greatest Weight Loss
A recent study from the University of Georgia found that the weight-loss drug tirzepatide is more effective than semaglutide…
-
GLP-1 Receptor Agonists May Promote Bone Health Alongside Weight Loss in Type 2 Diabetes
People living with type 2 diabetes face a hidden danger because the disease weakens their bones. This condition alters…
-
GLP-1 Receptor Agonists Reduce Major Kidney Events and Mortality in Transplant Recipients With Type 2 Diabetes
A systematic review of 7,012 kidney transplant recipients with type 2 diabetes shows that specific therapy offers survival benefits….
-
Understanding Why Patients Respond Differently to GLP-1 Drugs
GLP-1 receptor agonists offer a major advancement for managing obesity and type 2 diabetes. Medications like semaglutide and tirzepatide…
-
Wegovy for More Than Weight Loss: Seven Potential Health Advantages
Semaglutide, best known by its brand name Wegovy, has completely changed how we treat obesity. With an FDA-approved daily…
-
GLP-1 Receptor Agonists and Bile Acid Malabsorption: Emerging Evidence and Mechanisms
Bile acid malabsorption affects about 1% of the general population. This condition causes chronic and socially difficult symptoms. Patients…
-
Protecting Muscle Mass While Using GLP-1 Medications: A Nutrition Guide
New medications for weight loss have changed how we treat obesity and type 2 diabetes. These drugs, known as…
